Closed gudeqing closed 2 years ago
You are correct that the aggregate report's definition of "Expression" is defined as "RNA-expr*RNA_VAF" so if either of those or 0 or NA the variant gets binned in the NoExpr tier. The naming is confusing. We've started to call this new metric "Allele Expression" and with our next release will be including this metric in the aggregate report as an additional output column. Would it makes things easier to understand if we then also renamed the tier to be "NoAlleleExpr", "LowAlleleExpr", etc?
@susannasiebert I do not quite understand why we need to define expression as "RNA-expr*RNA_VAF" since this expression is quantified from tumor sample. If No RNA_VAF is available, why not directly set RNA_VAF = 1.0
If you have a cancer point mutation, it's generally going to be heterozygous, affecting only one of the two alleles. Many transcripts undergo allele-specific transcription, where only one of the two alleles is actually expressed. If the WT allele is being expressed (even at very high levels!), but the MT allele is silenced, then it's unlikely to be a good neoantigen candidate. Hope this explanation makes sense!
Hi:
Describe the bug "Tier" value in the final report is not consistent with "RNA_expr ". I guess this maybe caused by No RNA_VAF provided since you may calculate this by "RNA-expr*RNA_VAF" ?
To Reproduce vcf having gene expression but no RNA_VAF and RNA_Depth
Output File
Expected behavior "Tier" value in the final report is consistent with "RNA_expr ".